Ibrutinib-related atrial fibrillation: Therapeutic challenges

Chris J Kapelios1, Maria S Bonou1, Panagiotis Diamantopoulos2

  • 11 Department of Cardiology, Laiko General Hospital, Athens, Greece.

Insights

Ibrutinib treatment for lymphohyperplastic diseases can cause atrial fibrillation. Intravenous amiodarone successfully restored sinus rhythm in a challenging case, highlighting therapeutic options.

Area of Science:

  • Cardiology
  • Oncology
  • Pharmacology

Background:

  • Ibrutinib is a Bruton's tyrosine kinase inhibitor used for lymphoproliferative disorders.
  • Ibrutinib therapy is linked to an increased risk of atrial fibrillation (AF).
  • Managing new-onset AF in patients on ibrutinib presents therapeutic challenges due to contraindications for certain antiarrhythmics and anticoagulation limitations.

Purpose of the Study:

  • To describe the management of a patient with ibrutinib-associated new-onset atrial fibrillation.
  • To discuss the challenges in rhythm control and anticoagulation for this patient population.

Main Methods:

  • Case report of a 55-year-old patient on ibrutinib presenting with new-onset AF and borderline blood pressure.
  • Attempted rhythm control with intravenous amiodarone when first-line therapies (electrical cardioversion, ablation) were not feasible.

Main Results:

  • Intravenous amiodarone administration led to prompt restoration of sinus rhythm.
  • The patient's borderline arterial pressure was managed during treatment.

Conclusions:

  • Rhythm control with intravenous amiodarone can be effective for ibrutinib-associated AF when first-line options are contraindicated.
  • Careful consideration of anticoagulation and rhythm control strategies is crucial in these complex patients.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.0K
Amyloid Fibrils03:03

Amyloid Fibrils

6.5K
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
3.4K
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.9K
Therapeutic Communication01:30

Therapeutic Communication

Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
8.5K
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.5K